Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gionata Buggiani

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Italian Journal of Dermatology and Venereology|July 5, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologicsFrancesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology|November 7, 2024
Risankizumab in very elderly patients in real-world practiceElisa Lorenzoni, Antonella Di Cesare, Elia Rosi, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 13, 2020
Tuscan Consensus on the diagnosis, treatment and follow up of adult atopic dermatitisFilomena Russo, Nicola Milanesi, Michela Iannone, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Italian Journal of Dermatology and Venereology|July 5, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologicsFrancesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology|November 7, 2024
Risankizumab in very elderly patients in real-world practiceElisa Lorenzoni, Antonella Di Cesare, Elia Rosi, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 13, 2020
Tuscan Consensus on the diagnosis, treatment and follow up of adult atopic dermatitisFilomena Russo, Nicola Milanesi, Michela Iannone, et al.
Pageof 3